Choose a model
Each card values Greenlight Capital Re a different way, shown at our starting inputs. Pick one to see and change how it works.
Set your assumptions
Greenlight Capital Re on book value: book value per share (equity) grows with retained profit and is priced at a normal price-to-book. For banks and insurers.
Years to project
Growth of book value per share
Book value per share; starts at its own recent growth
Exit P/B
Starts at its own median P/B over five years
Your desired return
Margin of safety
More
Your buy price
The expected return is measured from it; starts at today's price
How it's worked out
Today's book value per share
Last twelve months
$21.54
Book value in 2031
Grows 9.9% a year for 5 years
$34.54
Price in 2031
$34.54 × 0.7 P/B
$24.18
Worth today
÷ 1.10^5: your 10% a year, taken back out
$15.01
Fair value
The most you can pay and still earn 10% a year
$15.01
Buy below
Fair value minus your 25% margin of safety
$11.26
Paying $16.37 instead gives 8.1% a year. Every rule is on the methodology page.
Outcome
What your assumptions give, and the path from today's price.
Fair value
$15.01
Expected return
8.1% a year
Future price, 2031
$24.18
Buy below
$11.26
Price 9% above fair valuePrice $16.37, at your 10% return
Projection
Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.
Greenlight Capital Re (GLRE) intrinsic value and fair value
The calculator grows one of Greenlight Capital Re's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for GLRE; this is analysis, not investment advice.
Frequently asked
What is Greenlight Capital Re's (GLRE) intrinsic value?+
With Intrinsiqq's starting inputs, Greenlight Capital Re's fair value is about $15.01 a share, based on its book value per share. That assumes book value per share of $21.54 grows about 9.9% a year for 5 years, the stock then trades at 0.7 times book value, and you want a 10.0% yearly return. On its other figures: earnings $25.88, free cash flow $28.84, revenue $15.09. Every input can be changed on the page; the result is a model, not a forecast.
Is Greenlight Capital Re overvalued?+
At $16.37, the price is 9% above that fair value of $15.01, and buying at today's price would return about 8.1% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from SEC filings, not investment advice.
What growth does the Greenlight Capital Re valuation assume?+
Book value per share grows about 9.9% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise). The exit multiple starts at its own median over five years.
What is a good margin of safety for Greenlight Capital Re?+
A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at $11.26. Less predictable businesses deserve a wider cushion, or a higher desired return.
Peers
Fire, Marine & Casualty Insurance · Pick stocks to compare with GLRE
Held by ETFs
GLRE is in 16 US ETFs. The largest of them, with GLRE's weight in each:
Avantis U.S. Small Cap Value ETFAVUV0.03%of the fund
iShares Russell 2000 Value ETFIWN0.03%of the fund
Dimensional U.S. Targeted Value ETFDFAT0.01%of the fund
Vanguard Financials Index Fund ETF SharesVFH0.00%of the fund
Spot a number that looks wrong? Check it in GLRE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GLRE
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.